Detalhe da pesquisa
1.
Clinical Relevance of Rifampicin-Moxifloxacin Interaction in Isoniazid-Resistant/Intolerant Tuberculosis Patients.
Antimicrob Agents Chemother;
66(2): e0182921, 2022 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34807758
2.
The case for expanding worldwide access to point of care molecular drug susceptibility testing for isoniazid.
Clin Microbiol Infect;
28(8): 1047-1049, 2022 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35378271